Adiposity and mortality among intensive care patients with COVID-19 and non-COVID-19 respiratory conditions: a cross-context comparison study in the UK.
Adiposity
BMI
COVID-19
Critical care
Epidemiology
ICNARC
Influenza
Intensive care
Mortality
Pneumonia
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
received:
22
10
2023
accepted:
29
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
13
9
2024
Statut:
epublish
Résumé
Adiposity shows opposing associations with mortality within COVID-19 versus non-COVID-19 respiratory conditions. We assessed the likely causality of adiposity for mortality among intensive care patients with COVID-19 versus non-COVID-19 by examining the consistency of associations across temporal and geographical contexts where biases vary. We used data from 297 intensive care units (ICUs) in England, Wales, and Northern Ireland (Intensive Care National Audit and Research Centre Case Mix Programme). We examined associations of body mass index (BMI) with 30-day mortality, overall and by date and region of ICU admission, among patients admitted with COVID-19 (N = 34,701; February 2020-August 2021) and non-COVID-19 respiratory conditions (N = 25,205; February 2018-August 2019). Compared with non-COVID-19 patients, COVID-19 patients were younger, less often of a white ethnic group, and more often with extreme obesity. COVID-19 patients had fewer comorbidities but higher mortality. Socio-demographic and comorbidity factors and their associations with BMI and mortality varied more by date than region of ICU admission. Among COVID-19 patients, higher BMI was associated with excess mortality (hazard ratio (HR) per standard deviation (SD) = 1.05; 95% CI = 1.03-1.07). This was evident only for extreme obesity and only during February-April 2020 (HR = 1.52, 95% CI = 1.30-1.77 vs. recommended weight); this weakened thereafter. Among non-COVID-19 patients, higher BMI was associated with lower mortality (HR per SD = 0.83; 95% CI = 0.81-0.86), seen across all overweight/obesity groups and across dates and regions, albeit with a magnitude that varied over time. Obesity is associated with higher mortality among COVID-19 patients, but lower mortality among non-COVID-19 respiratory patients. These associations appear vulnerable to confounding/selection bias in both patient groups, questioning the existence or stability of causal effects.
Sections du résumé
BACKGROUND
BACKGROUND
Adiposity shows opposing associations with mortality within COVID-19 versus non-COVID-19 respiratory conditions. We assessed the likely causality of adiposity for mortality among intensive care patients with COVID-19 versus non-COVID-19 by examining the consistency of associations across temporal and geographical contexts where biases vary.
METHODS
METHODS
We used data from 297 intensive care units (ICUs) in England, Wales, and Northern Ireland (Intensive Care National Audit and Research Centre Case Mix Programme). We examined associations of body mass index (BMI) with 30-day mortality, overall and by date and region of ICU admission, among patients admitted with COVID-19 (N = 34,701; February 2020-August 2021) and non-COVID-19 respiratory conditions (N = 25,205; February 2018-August 2019).
RESULTS
RESULTS
Compared with non-COVID-19 patients, COVID-19 patients were younger, less often of a white ethnic group, and more often with extreme obesity. COVID-19 patients had fewer comorbidities but higher mortality. Socio-demographic and comorbidity factors and their associations with BMI and mortality varied more by date than region of ICU admission. Among COVID-19 patients, higher BMI was associated with excess mortality (hazard ratio (HR) per standard deviation (SD) = 1.05; 95% CI = 1.03-1.07). This was evident only for extreme obesity and only during February-April 2020 (HR = 1.52, 95% CI = 1.30-1.77 vs. recommended weight); this weakened thereafter. Among non-COVID-19 patients, higher BMI was associated with lower mortality (HR per SD = 0.83; 95% CI = 0.81-0.86), seen across all overweight/obesity groups and across dates and regions, albeit with a magnitude that varied over time.
CONCLUSIONS
CONCLUSIONS
Obesity is associated with higher mortality among COVID-19 patients, but lower mortality among non-COVID-19 respiratory patients. These associations appear vulnerable to confounding/selection bias in both patient groups, questioning the existence or stability of causal effects.
Identifiants
pubmed: 39272119
doi: 10.1186/s12916-024-03598-3
pii: 10.1186/s12916-024-03598-3
doi:
Types de publication
Journal Article
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
391Informations de copyright
© 2024. The Author(s).
Références
Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400(10359):1224–80.
pubmed: 36115368
pmcid: 9539542
doi: 10.1016/S0140-6736(22)01585-9
Censin JC, Peters SA, Bovijn J, Ferreira T, Pulit SL, Mägi R, et al. Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet. 2019;15(10):e1008405.
pubmed: 31647808
pmcid: 6812754
doi: 10.1371/journal.pgen.1008405
Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O’Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6· 9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350–9.
pubmed: 33932335
pmcid: 8081400
doi: 10.1016/S2213-8587(21)00089-9
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6.
pubmed: 32640463
pmcid: 7611074
doi: 10.1038/s41586-020-2521-4
Leong A, Cole JB, Brenner LN, Meigs JB, Florez JC, Mercader JM. Cardiometabolic risk factors for COVID-19 susceptibility and severity: a Mendelian randomization analysis. PLoS Med. 2021;18(3):e1003553.
pubmed: 33661905
pmcid: 7971850
doi: 10.1371/journal.pmed.1003553
Du Y, Lv Y, Zha W, Zhou N, Hong X. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis. Metabolism. 2021;117:154373.
pubmed: 32949592
doi: 10.1016/j.metabol.2020.154373
Gao M, Wang Q, Piernas C, Astbury NM, Jebb SA, Holmes MV, et al. Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis. Int J Obes (Lond). 2022;46(5):943–50.
pubmed: 35031696
doi: 10.1038/s41366-021-01054-3
Luo S, Liang Y, Wong THT, Schooling CM, Au Yeung SL. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies. Int J Epidemiol. 2022;51(4):1088–105.
pubmed: 35445260
doi: 10.1093/ije/dyac076
Clayton GL, Soares AG, Goulding N, Borges MC, Holmes M, Davey Smith G, et al. A framework for assessing selection and misclassification bias in mendelian randomisation studies: an illustrative example between body mass index and covid-19. BMJ. 2023;381:e072148.
Freuer D, Linseisen J, Meisinger C. Impact of body composition on COVID-19 susceptibility and severity: a two-sample multivariable Mendelian randomization study. Metabolism. 2021;118:154732.
pubmed: 33631142
pmcid: 7900753
doi: 10.1016/j.metabol.2021.154732
COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472–7.
doi: 10.1038/s41586-021-03767-x
O’Brien JM Jr, Phillips GS, Ali NA, Lucarelli M, Marsh CB, Lemeshow S. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med. 2006;34(3):738.
pubmed: 16521268
pmcid: 1868702
doi: 10.1097/01.CCM.0000202207.87891.FC
Karampela I, Chrysanthopoulou E, Christodoulatos GS, Dalamaga M. Is there an obesity paradox in critical illness? Epidemiologic and metabolic considerations. Curr Obes Rep. 2020;9(3):231–44.
pubmed: 32564203
doi: 10.1007/s13679-020-00394-x
Butler-Laporte G, Harroud A, Forgetta V, Richards JB. Elevated body mass index is associated with an increased risk of infectious disease admissions and mortality: a Mendelian randomization study. Clin Microbiol Infect. 2021;27(5):710–6.
doi: 10.1016/j.cmi.2020.06.014
Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166(6):646–55.
pubmed: 17615092
doi: 10.1093/aje/kwm165
Davey Smith G, Phillips AN. Correlation without a cause: an epidemiological odyssey. Int J Epidemiol. 2020;49(1):4–14.
pubmed: 32244255
doi: 10.1093/ije/dyaa016
Lawlor DA, Tilling K, Davey SG. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016;45(6):1866–86.
pubmed: 28108528
Munafò MR, Higgins JPT, Davey Smith G. Triangulating evidence through the inclusion of genetically informed designs. Cold Spring Harb Perspect Med. 2021;11(8):a040659.
pubmed: 33355252
pmcid: 8327826
doi: 10.1101/cshperspect.a040659
Brion MJA, Lawlor DA, Matijasevich A, Horta B, Anselmi L, Araújo CL, et al. What are the causal effects of breastfeeding on IQ, obesity and blood pressure? Evidence from comparing high-income with middle-income cohorts. Int J Epidemiol. 2011;40(3):670–80.
pubmed: 21349903
pmcid: 3147072
doi: 10.1093/ije/dyr020
Ferrando-Vivas P, Doidge J, Thomas K, Gould DW, Mouncey P, Shankar-Hari M, et al. Prognostic factors for 30-day mortality in critically ill patients with coronavirus disease 2019: an observational cohort study. Crit Care Med. 2021;49(1):102.
pubmed: 33116052
doi: 10.1097/CCM.0000000000004740
Doidge JC, Gould DW, Ferrando-Vivas P, Mouncey PR, Thomas K, Shankar-Hari M, et al. Trends in intensive care for patients with COVID-19 in England, Wales, and Northern Ireland. Am J Respir Crit Care Med. 2021;203(5):565–74.
pubmed: 33306946
pmcid: 7924583
doi: 10.1164/rccm.202008-3212OC
Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):1–12.
doi: 10.1038/s41467-020-19478-2
Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, et al. COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2020;46(11):2035–47.
pubmed: 33034689
pmcid: 7545019
doi: 10.1007/s00134-020-06267-0
Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database. Crit Care. 2004;8(2):1–13.
doi: 10.1186/cc3745
Intensive Care National Audit and Research Centre. ICNARC report on COVID-19 in critcal care: England, Wales and Northern Ireland: 6 July 2021. 2021
Charani E, Gharbi M, Hickson M, Othman S, Alfituri A, Frost G, et al. Lack of weight recording in patients being administered narrow therapeutic index antibiotics: a prospective cross-sectional study. BMJ Open. 2015;5(4):e006092.
pubmed: 25838504
pmcid: 4390734
doi: 10.1136/bmjopen-2014-006092
Toft-Petersen AP, Wulff J, Harrison DA, Ostermann M, Margarson M, Rowan KM, et al. Exploring the impact of using measured or estimated values for height and weight on the relationship between BMI and acute hospital mortality. J Crit Care. 2018;44:196–202.
pubmed: 29156253
doi: 10.1016/j.jcrc.2017.11.021
Harrell FE. Regression Modeling Strategies. With applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
doi: 10.1007/978-1-4757-3462-1
Munafò MR, Tilling K, Taylor AE, Evans DM, Davey SG. Collider scope: when selection bias can substantially influence observed associations. Int J Epidemiol. 2018;47(1):226–35.
pubmed: 29040562
doi: 10.1093/ije/dyx206
Boyd AP, Kittelson JM, Gillen DL. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring. Stat Med. 2012;31(28):3504–15.
pubmed: 22763957
doi: 10.1002/sim.5440
Xu RH, O’Quigley J. Estimating average regression effect under non-proportional hazards. Biostatistics. 2000;1(4):423–39.
pubmed: 12933565
doi: 10.1093/biostatistics/1.4.423
Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711–24.
pubmed: 33939953
pmcid: 8087292
doi: 10.1016/S0140-6736(21)00634-6
Aghili SMM, Ebrahimpur M, Arjmand B, Shadman Z, Pejman Sani M, Qorbani M, et al. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes (Lond). 2021;45(5):998–1016.
pubmed: 33637951
doi: 10.1038/s41366-021-00776-8
Abu-Raddad LJ, Chemaitelly H, Bertollini R. Severity of SARS-CoV-2 reinfections as compared with primary infections. N Engl J Med. 2021;385(26):2487–9.
pubmed: 34818474
doi: 10.1056/NEJMc2108120
Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741–5.
pubmed: 33436525
pmcid: 7932103
doi: 10.1126/science.abe6522
Bernal JL, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088.
doi: 10.1136/bmj.n1088
Millard LAC, Fernández-Sanlés A, Carter AR, Hughes RA, Tilling K, Morris TP, et al. Exploring the impact of selection bias in observational studies of COVID-19: a simulation study. Int J Epidemiol. 2023;52(1):44–57.
pubmed: 36474414
doi: 10.1093/ije/dyac221
Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021;19(1):1–26.
doi: 10.1186/s12916-021-02058-6
Kooistra EJ, Brinkman S, van der Voort PH, de Keizer NF, Dongelmans DA, Kox M, et al. Body mass index and mortality in coronavirus disease 2019 and other diseases: a cohort study in 35,506 ICU patients. Crit Care Med. 2022;50(1):e1.
pubmed: 34374504
doi: 10.1097/CCM.0000000000005216
Recalde M, Pistillo A, Fernandez-Bertolin S, Roel E, Aragon M, Freisling H, et al. Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: a cohort study of 2 524 926 Catalans. J Clin Endocrinol Metab. 2021;106(12):e5030–42.
pubmed: 34297116
Vera-Zertuche J, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, Aguirre-García M, Segura-Badilla O, et al. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study. Epidemiol Infect. 2021;149:e109.
pubmed: 33913410
doi: 10.1017/S0950268821001023
Yates T, Zaccardi F, Islam N, Razieh C, Gillies CL, Lawson CA, et al. Obesity, ethnicity, and risk of critical care, mechanical ventilation, and mortality in patients admitted to hospital with COVID-19: analysis of the ISARIC CCP-UK Cohort. Obesity (Silver Spring). 2021;29(7):1223–30.
pubmed: 33755331
doi: 10.1002/oby.23178
Espiritu AI, Reyes NGD, Leochico CFD, Sy MCC, Villanueva EQ III, Anlacan VMM, et al. Body mass index and its association with COVID-19 clinical outcomes: findings from the Philippine CORONA study. Clin Nutr ESPEN. 2022;49:402–10.
pubmed: 35623845
pmcid: 8968152
doi: 10.1016/j.clnesp.2022.03.013
Friedman AN, Guirguis J, Kapoor R, Gupta S, Leaf DE, Timsina LR, et al. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021;29(10):1719–30.
pubmed: 34109768
doi: 10.1002/oby.23245
Huang HK, Bukhari K, Peng CCH, Hung DP, Shih MC, Chang RHE, et al. The J-shaped relationship between body mass index and mortality in patients with COVID-19: a dose-response meta-analysis. Diabetes Obes Metab. 2021;23(7):1701.
pubmed: 33764660
pmcid: 8250762
doi: 10.1111/dom.14382
Paolini JBM, Mancini J, Genestal M, Gonzalez H, McKay RE, Samii K, et al. Predictive value of abdominal obesity vs. body mass index for determining risk of intensive care unit mortality. Crit Care Med. 2010;38(5):1308–14.
pubmed: 20228682
doi: 10.1097/CCM.0b013e3181d8cd8b
Bell JA, Carslake D, O’Keeffe LM, Frysz M, Howe LD, Hamer M, et al. Associations of body mass and fat indexes with cardiometabolic traits. J Am Coll Cardiol. 2018;72(24):3142–54.
pubmed: 30545453
pmcid: 6290112
doi: 10.1016/j.jacc.2018.09.066
Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM. Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17(3):262–75.
pubmed: 26663309
doi: 10.1111/obr.12358
Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a metaanalysis among different ethnic groups. Int J Obes (Lond). 1998;22(12):1164–71.
doi: 10.1038/sj.ijo.0800741
Stensrud MJ, Hernán MA. Why Test for Proportional Hazards? JAMA. 2020;323(14):1401–2.
pubmed: 32167523
doi: 10.1001/jama.2020.1267